ARTICLE | Company News
atugen, Serono in validation deal
June 28, 2001 7:00 AM UTC
atugen (Berlin, Germany) will use its gene target validation services on certain cell lines supplied by the Serono Pharmaceutical Research Institute, a division of Serono (SWX:SEO; SRA) with the aim o...